ERβ upon binding to its ligand oestrogen, dimerizes and translocates to the nucleus where the E2–ERβ complex transcriptionally upregulates target genes which, unlike E2–ERα, promote proapoptotic and antiproliferative responses in CRC. This evidence concerns the gene ESR2 and colorectal carcinoma.